Bolorforosh Said 4
4 · HAEMONETICS CORP · Filed Sep 3, 2019
Insider Transaction Report
Form 4
Bolorforosh Said
EVP, Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2019-08-30$93.52/sh+832$77,809→ 2,973 total - Sale
Common Stock
2019-08-30$133.73/sh−657$87,861→ 2,316 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2019-08-30−832→ 2,498 totalExercise: $93.52From: 2019-06-11Exp: 2025-06-11→ Common Stock (832 underlying)
Footnotes (2)
- [F1]This number includes unvested restricted stock units previously reported.
- [F2]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.